Literature DB >> 12471614

Beta2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3, -8 and -9 pathways but through increased reactive oxygen species.

John Gordon1, Ching-Huang Wu, Mojgan Rastegar, Ahmad R Safa.   

Abstract

Exogenous beta(2)-microglobulin (beta(2)m) induces significant apoptosis in the CCRF-HSB-2 human lymphoblastic leukemia cell line as detected by DNA fragmentation, DAPI staining and annexin V binding assay. beta(2)m treatment induced the release of cytochrome c and apoptosis-inducing factor (AIF) from the mitochondria, but no change in mitochondrial membrane potential (DeltaPsim) was observed during apoptosis, suggesting that cytochrome c may be released through a mechanism independent of mitochondrial permeability transition (MPT) pore formation. Moreover, the beta(2)m-induced release of cytochrome c and AIF from the mitochondria in CCRF-HSB-2 cells was caspase-independent, since Z-VAD-fmk, a general inhibitor of caspases, did not block the release of these factors. However, Z-VAD-fmk treatment significantly blocked beta(2)m-induced apoptosis, while Western blot analysis revealed that caspases-1, -2, -3, -6, -7, -8 and -9 are not activated during beta(2)m-induced apoptosis in these cells. These results collectively indicate that a post-mitochondrial caspase-dependent mechanism is involved in beta(2)m-induced apoptosis. Moreover, beta(2)m significantly enhanced the production of reactive oxygen species (ROS) during 12-48 hr treatment, and beta(2)m-induced apoptosis was almost totally inhibited in cells pre-treated with the antioxidant N-acetylcysteine (NAC), providing evidence that beta(2)m-induced apoptosis in CCRF-HSB-2 cells is ROS-dependent. Therefore, these results reveal that beta(2)m-induced apoptosis in CCRF-HSB-2 cells may occur through an unknown caspase-dependent and ROS-dependent mechanism(s) that is associated with cytochrome c and AIF release from mitochondria, but is independent of the caspase -3, -8 and -9 pathways. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12471614     DOI: 10.1002/ijc.10828

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.

Authors:  Khadijeh Bijangi-Vishehsaraei; Mohammad Reza Saadatzadeh; Su Huang; Ahmad R Safa; Michael P Murphy
Journal:  Mol Cell Biochem       Date:  2010-05-06       Impact factor: 3.396

2.  Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.

Authors:  Pramod Kumar Gautam; Arbind Acharya
Journal:  Tumour Biol       Date:  2014-11-28

3.  Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils.

Authors:  Sofia Giorgetti; Sara Raimondi; Katiuscia Pagano; Annalisa Relini; Monica Bucciantini; Alessandra Corazza; Federico Fogolari; Luca Codutti; Mario Salmona; Palma Mangione; Lino Colombo; Ada De Luigi; Riccardo Porcari; Alessandra Gliozzi; Massimo Stefani; Gennaro Esposito; Vittorio Bellotti; Monica Stoppini
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

4.  Cypermethrin induces Sertoli cell apoptosis through mitochondrial pathway associated with calcium.

Authors:  Heng-Xue Wang; Rui Zhang; Zheng Li; Lu-Shan Wang; Yue Yu; Qi Wang; Zhen Ding; Jin-Peng Zhang; Mei-Rong Zhang; Li-Chun Xu
Journal:  Toxicol Res (Camb)       Date:  2021-06-19       Impact factor: 2.680

5.  Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to MECP2 Gain- and Loss-of-Function Involves MeCP2 Isoform-Specific Homeostasis in the Brain.

Authors:  Marjorie Buist; Nada El Tobgy; Danilo Shevkoplyas; Matthew Genung; Annan Ali Sher; Shervin Pejhan; Mojgan Rastegar
Journal:  Cells       Date:  2022-04-24       Impact factor: 7.666

6.  Bullatacin triggered ABCB1-overexpressing cell apoptosis via the mitochondrial-dependent pathway.

Authors:  Yong-Ju Liang; Xu Zhang; Chun-Ling Dai; Jian-Ye Zhang; Yan-Yan Yan; Mu-Sheng Zeng; Li-Ming Chen; Li-Wu Fu
Journal:  J Biomed Biotechnol       Date:  2009-07-21

7.  Micro-heterogeneity and aggregation in beta2-microglobulin solutions: effects of temperature, pH, and conformational variant addition.

Authors:  Roberto Piazza; Matteo Pierno; Sara Iacopini; Palma Mangione; Gennaro Esposito; Vittorio Bellotti
Journal:  Eur Biophys J       Date:  2006-03-07       Impact factor: 1.733

8.  HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

Authors:  M Kontro; A Kumar; M M Majumder; S Eldfors; A Parsons; T Pemovska; J Saarela; B Yadav; D Malani; Y Fløisand; M Höglund; K Remes; B T Gjertsen; O Kallioniemi; K Wennerberg; C A Heckman; K Porkka
Journal:  Leukemia       Date:  2016-08-08       Impact factor: 12.883

9.  Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements.

Authors:  Carl O Olson; Robby M Zachariah; Chinelo D Ezeonwuka; Vichithra R B Liyanage; Mojgan Rastegar
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

Review 10.  β2-Microglobulin-mediated signaling as a target for cancer therapy.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Sajni Josson; Hiromitsu Mimata; Leland W K Chung
Journal:  Anticancer Agents Med Chem       Date:  2014-03       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.